vTv Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
High Point, NC
SEC filing record 1 source field available
Fiscal year end
31 December
vTv Therapeutics Inc. has filed 595 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 51-75 of 595 matching filings.

Per page
25
Current page
3
144 File 001-37524

144 filing

Filing date
01 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37524

144 filing

Filing date
29 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37524

DEF 14A

Filing date
25 Apr 2025
Reporting date
10 Jun 2025
Next action
Verify source filing
4

FORM 4

Filing date
24 Apr 2025
Reporting date
25 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37524

144 filing

Filing date
24 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
11 Apr 2025
Reporting date
11 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Mar 2025
Reporting date
01 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Dec 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Dec 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Nov 2024
Reporting date
15 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88973

SC 13G filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .